Here, we investigated the molecular mechanisms of receptor assembling involved in the mutated ALK2 signaling pathway and examined the potential of a blocking antibody that inhibits ligand-dependent signal induction through mutated ALK2 as an effective drug for FOP. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.